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Background: Clostridium botulinum strains that produce botulinum neurotoxin type E (BoNT/E) are most commonly
isolated from botulism cases, marine environments, and animals in regions of high latitude in the Northern
hemisphere. A strain of C. botulinum type E (CDC66177) was isolated from soil in Chubut, Argentina. Previous
studies showed that the amino acid sequences of BoNT/E produced by various strains differ by < 6% and that the
type E neurotoxin gene cluster inserts into the rarA operon.
Results: Genetic and mass spectral analysis demonstrated that the BoNT/E produced by CDC66177 is a novel toxin
subtype (E9). Toxin gene sequencing indicated that BoNT/E9 differed by nearly 11% at the amino acid level
compared to BoNT/E1. Mass spectrometric analysis of BoNT/E9 revealed that its endopeptidase substrate cleavage
site was identical to other BoNT/E subtypes. Further analysis of this strain demonstrated that its 16S rRNA sequence
clustered with other Group II C. botulinum (producing BoNT types B, E, and F) strains. Genomic DNA isolated from
strain CDC66177 hybridized with fewer probes using a Group II C. botulinum subtyping microarray compared to
other type E strains examined. Whole genome shotgun sequencing of strain CDC66177 revealed that while the
toxin gene cluster inserted into the rarA operon similar to other type E strains, its overall genome content shared
greater similarity with a Group II C. botulinum type B strain (17B).
Conclusions: These results expand our understanding of the global distribution of C. botulinum type E strains and
suggest that the type E toxin gene cluster may be able to insert into C. botulinum strains with a more diverse
genetic background than previously recognized.
Keywords: Botulism, Mass spectrometry, Genomics, Whole genome sequencingBackground
There are 7 serotypes (types A-G) of botulinum neuro-
toxins (BoNT) and types A, B, E or F are the most fre-
quent causes of botulism in humans. Strains of
Clostridium botulinum producing BoNT/E share similar
metabolic characteristics including the inability to digest
proteins such as gelatin, casein, or meat. These non-
proteolytic strains are psychrophilic with the ability to
grow at refrigeration temperatures [1]. In rare cases,* Correspondence: BRaphael@cdc.gov
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reproduction in any medium, provided the orstrains of Clostridium butyricum have been shown to
produce BoNT/E [2].
Clostridium botulinum type E strains can be isolated
from various marine environments and cases of botulism
due to BoNT/E typically occur in Canada, Alaska,
Northern Europe, and Japan [3]. A total of 56 cases of
type E botulism were reported to the Centers for Disease
Control and Prevention between 2001–2010 and 87.5%
of these cases occurred in Alaska (http://www.cdc.gov/
nationalsurveillance/botulism_surveillance.html). Type E
botulism has also occurred in the lower 48 states includ-
ing various outbreaks associated with smoked fish from
the Great Lakes [4,5]. A recent outbreak of botulism in
birds and fish in the Great Lakes region was attributedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the organism was also found in lake sediment [6]. A case
of infant botulism occurred in Illinois in 2007 although
the source of spores in this case could not be deter-
mined [7].
Genetic analysis of 16S rRNA sequences from various
C. botulinum strains reveals the presence of distinct
phylogenetic groups (I-IV) [8,9] which correspond to
previously recognized metabolic differences. All Group
II strains are non-proteolytic and include type E strains
and some type B and type F strains. Nucleotide sequen-
cing of various toxin genes has demonstrated the pres-
ence of amino acid variation within genes encoding a
single toxin serotype and these variants are identified as
toxin subtypes [9,10]. Among type E strains, a total of 8
such subtypes (E1-E8) have been identified [11]. These
subtypes differ at the amino acid level by up to 6%.
The genes encoding BoNT/A-G are found in toxin














































Figure 1 Dendrogram of bont/E nucleotide sequences. Shown is a neig
values (based on 100 replications) and genetic distance (bar) shown. BoNT
Accession numbers for bont/E genes not sequenced in this study are indicand regulatory proteins. The gene encoding BoNT/E is
found within a toxin gene cluster that includes ntnh
(nontoxic nonhemagglutinin), p47, and orfX1-3 [12,13].
Hill et al. [13] demonstrated that the bont/E toxin gene
cluster inserted into the rarA operon. The transposon-
associated gene, rarA, likely plays a role in this insertion
event in which the gene is split into small and large frag-
ments that flank the toxin gene cluster [13]. Remarkably,
an intact rarA gene is also located within the toxin gene
cluster and the nucleotide sequences of the intact and
split genes were shown to differ by phylogenetic analysis.
Moreover, the split rarA gene fragments can be pasted
together to form a gene with a nucleotide sequence with
similarity to the gene found in the Group II C. botulinum
type B strain 17B. In another study, the intact and split
rarA genes were detected across a panel of 41 type
E strains [11].
In this study, we characterized a previously unreported
C. botulinum type E strain isolated in 1995 from soil in CDC66177 E9
hbor-joining tree of bont/E nucleotide sequences with bootstrap
/E subtypes (E1-E9) encoded by clusters of genes are also shown.
ated with an asterisk.
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type E strain (CDC66177) originating from the Southern
hemisphere. We further show evidence that this strain
produces a unique type E toxin subtype and that the
genetic background of this strain is highly divergent
compared to other type E strains.
Results and discussion
Phylogenetic analysis of bont/E in C. botulinum strains
The nucleotide sequence of the entire bont/E gene was
determined for each of the 16 C. botulinum type E
strains examined in this study. Previous studies have
identified several bont/E subtypes [9-12]. Nucleotide
sequences of bont/E determined in this study were com-
pared along with representatives of other reported bont/
E subtypes (Figure 1). It is important to note that in
some cases strain names used in previous reports may
not refer to identical strains examined in this study with
a similar name. For instance, the CDC reference strain
labeled “Alaska” harbored a gene encoding a subtype E2
toxin and is unlikely to be related to the genome-
sequenced strain Alaska E43 (Genbank accession num-
ber: NC_010723) which encodes a subtype E3 toxin.
Another strain labeled “Minnesota” was distinguished
from a strain with the same name reported by Macdo-
nald et al. [11]. The CDC Minnesota strain harbored
an E7 subtype-encoding gene while the strain exam-
ined by Macdonald et al. [11] encoded an E3 subtype
toxin.
Strain CDC66177 harbored a significantly divergent
bont/E gene which formed a unique clade when com-
pared to other bont/E genes. Comparison of the trans-
lated amino acid sequence of this gene with the gene
encoding BoNT/E1 in strain Beluga indicated that the
sequences differed by ~11%. Since previous comparisonsFigure 2 Comparative analysis of representative BoNT/E subtypes. Sh
amino acid sequences to BoNT/E9 (from strain CDC66177). The most diverg
representative strains examined in this study or accession numbers retrieve
Alaska; E3, CDC40329; E4, AB088207 E5, AB037704; E6, AM695752; E7, Minnof BoNT/E subtypes resulted in differences of up to 6%
amino acid sequence variation, the BoNT/E produced by
strain CDC66177 can be considered a unique subtype
(E9) [10,11]. Comparison of the amino acid sequence of
BoNT/E9 with representatives of BoNT/E subtypes E1-
E8 demonstrated that the most divergent region of the
toxin was located in the last ~200 residues (Figure 2)
which corresponds to the C-terminal part of the heavy
chain (Hc-C) that is involved with binding to neuronal
cells [14]. BLAST analysis of this region indicated < 75%
amino acid sequence identity with other BoNT/E
sequences.
BLAST analysis of the 16S rRNA nucleotide se-
quence from strain CDC66177 shared > 99.8% identity
with strains Alaska E43 and 17B indicating that
the strain clusters with other Group II C. botulinum
strains [9].
Mass spectrometric analysis of BoNT/E produced by strain
CDC66177
Since the BoNT/E produced by strain CDC66177
appeared to be a previously unreported toxin subtype,
the enzymatic light chain activity of the toxin was
assessed in culture supernatants generated from the
strain. The light chain of BoNT/E cleaves the synaptoso-
mal-associated protein, SNAP-25, and the Endopep-MS
method was used to measure this activity upon a specific
peptide substrate mimic of SNAP-25 (IIGNLRH-
MALDMGNEIDTQNRQIDRIMEKADSNKT). Endopep-
MS analysis revealed that the toxin cleaved the peptide
substrate for BoNT/E in the expected location, resulting
in products with peaks at m/z 1136.8 and 2924.2 [15]
(Figure 3A).
BoNT/E9 extracted from culture supernatants of








own is a similarity plot comparing representative BoNT/E subtype
ent region of the amino acid sequence is shaded. Sequences from
d from Genbank are compared in the plot as follows: E1, Beluga; E2,
esota; E8, JN695730.
1     MPKINSFNYNDPVNDNTILYIKPGGCQQFYKSFNIMKNIWIIPERNVIGTIPQNFLPPTS 60
61    LKNGDSSYYDPNYLQNDQEKDRFLKIVTKVFNRINDNLSGRILLEELSKANPYLGNDNTR 120
121   DDDFIINDGSAVPIQFSNGSQSILLPTVIIMGAEPDLFETNSSNVSLINNYSPSNHGFGS 180
181   IAIVTFSPEYSFRFNDNSMNEFIQDPALTLIHELIHSLHGLYGAKGITTKYTITQQQNPL 240
241   ITNIRGINIEEFLTFGGNNLNIITSSQLNDIYTNLLDDYKKIASKLSKVQVSNPQLNPYK 300
301   DVFQEKYGLDKNASGIYSVNINKFNDIFKKLYSFTEFDLATKFQVKCRETYIGQYKYFKL 360
361   SNLLNDSIYNISEGYNINTLNVNFRGQNPNLNPRIITPITDRGLVKKIIRFCKNIVSVKG   420
421   IRKSICIEVNNGDLFFVASEKSYNNDSINIPKEIDDTVTLNNNYENDLDQVILNFNSESA 480
481   PGLSDKKLNISIQDDVYIPKYDSNGTSDIEQYDVSELNVFFYLDAQKVPEGENNVNLTSS 540
541   IDTALLEQSKIYTFFSSEFINNVNKPVQAALFVGWIQQVLVDFTTEATQKSTVDKIADIS 600
601   IVVPYIGLALNIGNESQKGNFKDALELLGAGILLEFVPELLIPTILVFTIKSFLGSSDNK 660
661   NKVIKAINNALKERDEKWKEVYSFIVSNWITKINTQFNKRKEQMYQALQNQVNALKTIIE 720
721   SKYNSYTLEEKNELTNKYDIEQIENELNQKVSIAMNNIDRFLTESSISYLMKLINEVKIN 780
781   KLREYDENVKTYLLDYITKHGSILGESQQELNSMIIDTLNNSIPFKLSSYTDDKILISYF 840
841   NKFFKTIKSSSVLSMRYKNDKYIDTSGYDSNININGDVFIYPTNKNQFGIYNSKLSEVNI 900
901   SQNDYIIYDNKYKNFSISFWVRIPNYNNKIVNVNNEYTIINCMRDNNSGWKISLNHNEII 960
961   WTLQDNAGINQKLVFKYGNANGISDYINKWIFVTITNDRLGYSKLYINGHLIDQKSILNL 1020
1021  GNIHVSDNILFKIVNCSYTRYIGMRYFNIFDKELDETEIQTLYNNEPNANVLKDFWGNYL 1080
1081  LYNKEYYLLNMLKPSKTISHNRDLTFSIYNNRNIVNGLYRLYSGIKVKIQKINDSDTRDN 1140
1141  IVRDNDQVYVNYINGNVYYSLYADTNATNKEKTIKSSTSGNRFNQVVVMNSVRNNCTMNF 1200
1201  KNNNGHDIGLLGFKSNALVASTWYYTNMRDHTNSNGCFWSFIPEENGWQEH 1260
*
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Figure 3 Mass spectral analysis of BoNT/E9. Panel A shows the products of endopeptidase cleavage of a type E specific peptide substrate
detected by mass spectrometry. Peaks indicating the cleavage of the substrate by the toxin are marked with asterisks. Panel B illustrates the
sequence coverage of BoNT/E9 amino acid sequence determination (in red font) of tryptic digestion products using mass spectrometry.
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http://www.biomedcentral.com/1471-2180/12/245the products were analyzed by mass spectrometry to
confirm that the toxin's amino acid sequence was indeed
unique based on the predicted translation of the DNA
sequence. The amino acid sequence of BoNT/E9 was
determined with 94.5% coverage (Figure 3B).0.060.080.100.12
Figure 4 Microarray analysis of Group II C. botulinum strains. Microarr
compared with a UPGMA dendrogram. Type E strains are shown in red, typ
Cluster 1 consists entirely of type E strains, however, strain CDC66177 grouDNA microarray analysis of strain CDC66177
A Group II C. botulinum subtyping DNA microarray
[16] was used to evaluate gene content in a panel of 21
Group II strains from the CDC culture collection.

























ay hybridization profiles of Group II type B, E, and F strains were
e B strains are shown in blue, and type F strains are shown in green.
ps with Cluster 2.
Figure 5 Southern hybridization of the rarA operon. Schematic
representations of the regions surrounding the rarA operon are
shown. The intact rarA gene in strain 17B or the split rarA fragments
in strain Beluga are shaded. The probe used in the accompanying
Southern blot (lane 1, 17B; lane 2, Beluga; and lane 3, CDC66177)
targeted either the intact rarA gene in strain 17B or the larger rarA
fragment (indicated by an asterisk) in strain Beluga. XbaI restriction
sites are indicated by a red line and expected fragment sizes are
shown.
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Alaska E43 and 5 additional probes targeting genes
present on the bont/B-encoding plasmid (pCLL) in
C. botulinum type B strain 17B. Genomic DNA isolated
from 15 type E strains (not including CDC66177) hybri-
dized with 90.5% of the probes on this array while DNA
isolated from type B strains (N=4) and type F strains
(N=2) hybridized with 71.9% and 71.0% of the probes,
respectively. Genomic DNA from strain CDC66177
hybridized with 66.8% of the probes present on the array.
Comparison of the profile of present or absent genes
demonstrated the presence of two clusters of strains
(Figure 4). Cluster 1 consisted entirely of type E strains.
Interestingly, strain CDC66177 grouped with cluster 2
which included the Group II type B and type F strains
examined in this study.
Southern hybridization of the split rarA gene in
strain CDC66177
In order to determine if the toxin gene cluster in
CDC66177 inserted into the rarA operon as described
for other type E strains [11,13], we performed Southern
hybridization using a probe that binds to the larger split
rarA gene fragment in type E strains or the intact rarA
gene in the type B strain 17B. Genomic DNA isolated
from CDC66177, Beluga, and 17B was digested with
XbaI and hybridized with the probe. The presence of
XbaI sites flanking the intact rarA gene in strain 17B
generated a ~2.8 kb fragment that hybridized the rarA
probe shown in Figure 5. A ~7.4 kb fragment hybridized
with the rarA probe in DNA isolated from strain Beluga.
These results were expected based on analysis of the
C. botulinum type E strain Beluga genome sequence
(Genbank accession number: ACSC01000002) which
demonstrated the presence of separate XbaI sites flank-
ing the larger split rarA than found at the corresponding
intact rarA gene in strain 17B (Genbank accession num-
ber: NC_010674). The rarA probe hybridized a similar
size fragment in several other type E strains examined
(data not shown). Unexpectedly, a ~1.7 kb band was
hybridized by the probe using DNA isolated from strain
CDC66177 suggesting the possibility that the regions
flanking the toxin gene insertion in this strain were not
similar to those of other type E strains.
Whole genome shotgun sequencing of strain CDC66177
Since the region flanking the rarA operon in strain
CDC66177 was suspected to be unlike that of other
type E strains, whole genome shotgun sequencing of
this strain was performed using the PacBio SMRT se-
quencer. An ~3.85 Mb draft sequence consisting of 120
contigs was assembled (Genbank accession number:
ALYJ00000000). Analysis of this sequence revealed that
the toxin gene cluster inserted into the rarA operon(Figure 6). The nucleotide sequence of the bont/E gene
extracted from the genome sequence data was identical to
that determined previously by Sanger sequencing. The nu-
cleotide sequence of a ~7.9 kb region starting at alaS
and extending through CLH_1119 (relative to Alaska E43)
was similar to that found in strain 17B but differed from
the sequences found in strains Alaska E43 and Beluga.
As shown in Figure 6, the regions between orfX3 and
the larger split rarA fragment (region I) and between the
smaller split rarA fragment and bont/E (region II) con-
tain insertion sequences that are likely involved with
transposon-mediated mobility of the toxin gene cluster
[13]. It is notable that regions I and II differ in size and
nucleotide sequence between strains Alaska E43 and
CDC66177. In order to determine if the nucleotide
sequences of these regions are strain-specific, we also per-
formed an alignment of these regions with strain Beluga.
Interestingly, region I in strain Beluga differed from both
CDC66177 and Alaska E43 while region II was identical
to that found in Alaska E43. While the mechanism of
toxin gene cluster insertion into the rarA operon is un-
clear, the sequence similarity in region II between strains
Beluga and Alaska E43 suggests at least a partial similarity
in the origin of the recombination event that results in the
insertion of the toxin gene cluster. However, strain
























































Figure 6 Organization of the toxin gene cluster and surrounding regions in CDC66177. The arrangement of genes in the toxin gene
cluster and surrounding regions of strain CDC66177 is compared to that of Alaska E43. The toxin gene cluster of strain CDC66177 is located
within the rarA operon similar to the arrangement in strain Alaska E43. Regions I and II (indicated by green font) contain putative insertion
sequences and the location of split and intact rarA genes are shown. XbaI restriction sites (indicated by red lines) flanking the larger split rarA
gene (indicated by an asterisk) are shown. The nucleotide sequence between alaS and the larger split rarA gene of the indicated strains was used
to generate the neighbor-joining tree shown.
Table 1 Pairwise alignment of toxin gene cluster
components







orfX3 94.9 94.9 100
orfX2 91.1 91.1 99.5
orfX1 94.9 94.9 100
p47 88.2 88.2 100
ntnh 96.8 96.9 99.9
bont/E 93.9 94.1 99.3
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ation event resulting in the insertion of the toxin gene
cluster in strain CDC66177 originated differently com-
pared to strains Beluga or Alaska E43.
Analysis of the genome sequence data explains the un-
expected ~1.7 kb band hybridized by the rarA probe in
strain CDC66177. The presence of an XbaI site within
the toxin gene cluster of both CDC66177 and Alaska
E43 and an additional site downstream of the larger rarA
fragment in strain CDC66177 yield an ~1.7 kb fragment.
Notably the genome sequence of strain 17B also demon-
strates the presence of a XbaI site downstream of the in-
tact rarA gene. Similar to other type E toxin gene
clusters, strain CDC66177 contains an intact rarA gene
that does not hybridize the rarA probe used in our stud-
ies. BLAST analysis of this gene demonstrated 98% nu-
cleotide similarity with the gene present in Alaska E43.
Since the bont/E gene in strain CDC66177 displayed
significant divergence compared to other reported bont/
E genes, we compared the nucleotide sequences of the
remaining toxin gene cluster components (ntnh, p47,
orfX1-3) to those found in Alaska E43 and Beluga
(Table 1). While these genes are nearly identical in
Alaska E43 and Beluga, the genes in CDC66177 ranged
from 88.2-96.9% nucleotide identity compared to those
in Alaska E43 and/or Beluga.
In order to further investigate the genomic sequence of
strain CDC66177, the average nucleotide identity (ANI) of
this strain was compared to Alaska E43 and Beluga. Briefly,
1,020 nucleotide fragments of the query genome were com-
pared to the subject genome using BLAST to determine the
ANI value [17]. Richter and Rosselló-Móra [17] proposed
an ANI of 95-96% as the boundary of considering two gen-
omes as belonging to a single bacterial species. While com-
parison of the genomes of strains Alaska E43 and Belugaresulted in an ANI > 97%, comparison of strain CDC66177
with Alaska E43 and Beluga resulted in ANI values between
93-94% (Table 2). Interestingly, comparison of strain
CDC66177 with 17B displayed > 98% ANI while compari-
son of either Alaska E43 or Beluga with 17B resulted in ANI
values < 94%. Importantly, only the strain 17B chromosomal
sequence was used in these calculations. However, ANI cal-
culations were based on the entire CDC66177 genome se-
quence since it is unknown if any of the contigs represent
mobile elements such as plasmids. Notably, all three strains
(Alaska E43, Beluga, and CDC66177), share nearly identical
16S rRNA sequences and clearly cluster with Group II C.
botulinum (data not shown).
Our analysis of the genetic diversity of type E strains
using a DNA microarray was limited to those isolated from
botulism cases. Therefore, we considered the possibility
that strain CDC66177 was genotypically divergent since it
was isolated from an environmental source. We performed
an in silico analysis of multilocus sequence typing (MLST)
alleles from selected type E strains (representing isolates
from soil and/or sediment, different MLST clades, and dif-
ferent BoNT/E subtypes) reported by Macdonald et al.
Table 2 Average nucleotide identity (ANI) of genomic
sequences
Subject Sequence† Query Sequence % ANI
Beluga CDC66177 93.58
Beluga 17B 93.41
Beluga Alaska E43 97.91*
CDC66177 Beluga 93.50
CDC66177 17B 98.91*
CDC66177 Alaska E43 93.73
17B Beluga 93.53
17B CDC66177 98.97*
17B Alaska E43 93.67
Alaska E43 Beluga 97.78*
Alaska E43 CDC66177 93.63
Alaska E43 17B 93.50
† The following genome sequences were used in the ANI analysis: Beluga,
accession number: ACSC00000000 (4.0 Mb); CDC66177, accession number:
ALYJ00000000 (3.85 Mb); 17B, accession number: NC_010674.1 (3.85 Mb);
Alaska E43, NC_010723.1 (3.66 Mb).
* ANI values ≥ 96% are marked with an asterisk.
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from the genome sequences of strains 17B and CDC66177.
Not surprisingly, strains 17B and CDC66177 formed a sep-
arate clade when concatenated MLST alleles were com-
pared to other type E strains (Figure 7).
Conclusions
In a previous study [18], botulinum toxin-producing
clostridia were isolated from 23.5% of soil samples col-
lected in Argentina. The distribution of toxin serotypes
reported from the Southern region of ArgentinaFigure 7 In silico analysis of MLST alleles. Concatemers of MLST alleles f
shown. The scale represents number of differences. Strains isolated from so
CDC66177 clusters with strain 17B and separately from other type E strainsincluded types A, B, and F. In this study, we character-
ized a previously unreported C. botulinum type E strain
(CDC66177) isolated in 1995 from soil collected in
Chubut, Argentina. This region is located at a latitude of
approximately 43°S which is located as far from the
equator as the Great Lakes are located in the Northern
hemisphere. While strain CDC66177 was isolated from
soil in proximity to the Atlantic Ocean, it is notable that
no cases of type E botulism have been reported
in Argentina. This is the first known report of the isola-
tion of this strain and extends the known global distri-
bution of C. botulinum type E.
While the strain CDC66177 produces a novel BoNT/E
subtype, the toxin was shown to cleave a peptide sub-
strate in the same location as other BoNT/E subtypes. It
remains to be determined if the toxin produced by this
strain varies in its neuronal cell receptor compared to
other BoNT/E subtypes. Finally, the presence of bont/E
in the rarA operon of a strain with genetic similarity to
strain 17B raises the intriguing possibility of a bivalent
non-proteolytic strain expressing BoNT/E encoded by a
chromosomally located gene and BoNT/B encoded by a
plasmid (such as pCLL found in 17B).
Methods
Bacterial strains used in this study
Bacterial strains used in this study are listed in Table 3.
Strain CDC66177 was isolated in 1995 from soil col-
lected in Dolavon, Chubut, Argentina (located approxi-
mately 58 km from the Atlantic Ocean). The soil sample
was originally collected in 1993 in an urbanized area
next to a perennial shrub (Ligustrum sinense). All C.or each strain were aligned with CLUSTALW and a UPGMA tree is
il and/or sediment sources are indicated with an asterisk. Strain
.
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Glucose Yeast Extract Broth (TPGY) at 35°C under an-
aerobic conditions.
DNA extraction, genetic analysis, and DNA microarray
Genomic DNA used in Sanger sequencing and DNA
microarrays was extracted using the PureLink Genomic
DNA kit (Life Technologies, Grand Island, NY). Neuro-
toxin and 16S rRNA gene sequences were determined
using previously reported primers that amplified over-
lapping regions [9,19]. Phylogenetic analysis was per-
formed using CLUSTALX and the resulting phylogenetic
tree was rendered using MEGA 5.05 [20]. Comparative
analysis among representative BoNT/E subtypes was
performed using SimPlot (http://sray.med.som.jhmi.edu/
SCRoftware/simplot/) with a 200 amino acid window.
The Group II C. botulinum subtyping microarray was
designed as described elsewhere [16]. Briefly, the micro-
array featured 495 probes representing genes distributed
throughout the C. botulinum Alaska E43 genome se-
quence and 5 additional probes specific for pCLL which
encodes the toxin gene cluster in strain 17B. Microarray
spotting was performed by ArrayIt (Sunnyvale, CA) or
onsite using an Omnigrid Micro microarrayer (Digilab,
Holliston, MA). Genomic DNA was labeled with Cy5Table 3 Bacterial strains used in this study
Strain bont subtype Source L
Beluga† E1 Fermented whale A
CDC41648 E1 Seal flipper A
CDC42747 E1 Stool A
CDC42840 E1 Stool A
CDC47437 E1 Stool A
CDC5247 E2 Fermented seal flipper A
Alaska† E2 Unknown U
CDC52256 E3 Stool I
CDC59470‡ E3 Stink eggs A
CDC59471‡ E3 Stool A
CDC59498 E3 Stink head A
CDC42861 E3 Seal A
CDC40329 E3 Fish A
VH E3 Unknown U
Minnesota† E7 Unknown U
CDC66177 E9 Soil A
CDC38597 B4 Blood sausage I
17B† B4 Marine sediment P
CDC706 B4 Fermented salmon brine A
CDC30592 B4 Gastric fluid A
KA-173 (610B) F6 Salmon C
VPI7943 F6 Venison jerky C
† Strain provided by J. Ferreira (FDA, Atlanta, GA).
‡ Strains are associated with same botulism event.random primers and hybridized to the array as previ-
ously described [21]. The log of the ratio of the mean
fluorescence signal at 635 nm for triplicate probes com-
pared to background fluorescence (locations spotted
with buffer alone) was calculated. Log ratios ≥ 1.0 were
considered positive and those < 0.5 were considered
negative. Log ratios between 0.5 and < 1.0 were consid-
ered intermediate likely due to nucleotide sequence
variation [21]. Hybridization profiles were converted to
binary data by assigning 1 to positive probes and 0 to
negative and intermediate probes. Profiles were com-
pared using a UPGMA dendrogram generated with
DendroUPGMA (http://genomes.urv.cat/UPGMA/) and
selecting the Jaccard coefficient. Microarray data were
deposited in the Gene Expression Omnibus with series
accession number GSE40271.
Southern hybridization
Genomic DNA was digested with XbaI for 1 h and run
on a 1% TBE agarose gel. Alkaline transfer was per-
formed using the TurboBlotter system (Whatman, Kent,
ME). An 874 bp probe corresponding to the large rarA
fragment was generated by PCR amplification with
primers RarA-F and RarA-R (RarA-F, 50-GCAAGCA


















acific coast, US 1967 EF051570
laska 1977 JX437192
laska 1985 JX437194
olumbia River, US ~1966 GU213230
alifornia 1966 GU213228
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DNA Labeling and Detection kit (Roche, Indianapolis,
IN). Hybridization was carried out at 42°C in standard
hybridization buffer (5X SSC, 0.1% N-laurylsarcosine,
0.02% SDS, 1% Blocking buffer (from DIG DNA Labeling
and Detection kit).
Mass spectrometric analysis
Botulinum neurotoxin in culture supernatant CDC66177
was extracted and tested for light chain protease activity
in a manner similar to that previously described [15],
with the exception that 200 μL of culture supernatant
was used for this study. Briefly, the neurotoxin was
extracted from the culture supernatant using protein G
beads coated with antibodies to BoNT/E. Following
washing, the beads were then incubated for 4 h at 37°C
with a peptide substrate known to be cleaved by BoNT/
E in the presence of a reaction buffer. The reaction
supernatant was then analyzed by MALDI-TOF mass
spectrometry as described previously to determine the
location of cleavage of the peptide substrate.
The reaction supernatant was then completely
removed from the beads, and the toxin on the beads was
digested and analyzed by LC-MS/MS essentially as
described previously [22], with the exception that an
Orbitrap Elite was used in place of the fourier transform
magnetic trap. Briefly, the beads with toxin attached
were digested with trypsin and then chymotrypsin. The
resultant peptide mixtures were separated by nano-LC
and mass analyzed on an Orbitrap Elite, generating MS/
MS of the peptides. The MS/MS data were then
searched against a database indexed for only Clostridium
spp. for protein identification.
Whole genome sequencing and analysis
Genomic DNA was isolated from strain CDC66177
using the MasterPure kit (Epicenter, Madison, WI) with
modifications previously described [23]. This DNA was
further purified using a Genomic-tip 100/G column
(Qiagen, Valencia, CA). One microgram of genomic
DNA was sheared using a Covaris S2 ultrasonicator sys-
tem to a mean size of 1 Kb. The sheared DNA was used
to construct a SMRTbell sequencing library (Pacific
Biosciences) according to manufacturer’s instructions.
The SMRTbell library was then bound into SMRTbell-
DNA polymerase complexes and loaded into zero-mode
waveguides (ZMW) on 4 SMRTcells and sequenced
using Pacific Biosciences C2 chemistry. This relatively
small insert sized library was utilized to promote pro-
duction of circular concensus reads (CCS) which retain
higher accuracy base calls than the longer continuous
length reads (CLR). Eight 45 min movies were recorded
and processed, yielding ~305 K reads with a mean read-
length of 2.9 Kbases and total of 889 Mbases ofsequence. CCS reads (140 K reads) were then used to
error correct the longer (165 K reads) CLR reads [24]
utilizing the Pacific Biosciences analysis script BLASR
and then the combined CCS/corrected CLR fastq format
reads were imported into CLC Genomics workbench.
Sequence reads were then trimmed of any remaining
Pacific Biosciences hairpin adaptor sequences and qual-
ity trimmed to a base Q value of 20. The filtered reads
were then assembled de novo using the CLC denovo as-
sembler. The 188,898 input reads provided a draft as-
sembly of a 3.85 Mb genome comprised of 119 contigs
with an N50 value of 87,742 bases with an average
coverage of 28X.
Annotation of the whole genome sequence was
performed using RAST [25]. Pairwise alignments of
various genes were made with EMBOSS Needle (http://
www.ebi.ac.uk/Tools/psa/emboss_needle/nucleotide.html).
ANI values were determined using the computer pro-
gram JSpecies [17]. MLST loci from selected previously
reported type E strains were obtained from Genbank
[11]. These MLST loci were used to search for the corre-
sponding alleles in the strain 17B genome sequence and
the CDC66177 whole genome sequence using BLAST.
Concatemers of the alleles for each strain were gener-
ated and a multiple sequence alignment was performed
using CLUSTALW because the lengths of some alleles
in strains 17B and CDC66177 differed due to insertion
and/or deletions.
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